Stock DNA DNA GROUP (T.R.) LTD
Add to a list
To use this feature you must be a member
Log inSign up

Company Dna Group (T.R.) Ltd

Equities

DNA

IL0011038523

Biotechnology & Medical Research

Market Closed - TEL AVIV STOCK EXCHANGE
Other stock markets
 10:24:14 2024-06-27 EDT 		5-day change 1st Jan Change
72 ILa -4.26% Intraday chart for Dna Group (T.R.) Ltd +2.71% +13.92%
03-19 Dna Group (T.R.) Ltd Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Dna Group (T.R.) Ltd Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Business Summary

DNA Group TR Ltd, former DNA Biomedical Solutions Ltd, is an Israel-based company, which is engaged in the biotechnology sector. The Company's areas of activity include: the evaluation of bone density by measuring the velocity of the propagation of sound waves across the bone, using Bimmed, as well as the development of oral delivery of drugs, through its subsidiary, Entera Bio Ltd. Entera Bio Ltd focuses on the development of oral delivery of large molecules to address unmet medical needs. Entera Bio Ltd holds a patent, combining the following technologies: a synthetic molecule absorption enhancer, facilitating the absorption of large molecules and a proprietary formulation to prevent molecule degradation. Entera Bio Ltd’s proprietary oral delivery platform can be applied to a range of large molecules and biologicals. Entera Bio Ltd’s drugs are designated for the following medical conditions: Hypoparathyroidism and Osteoporosis.

Sales per Business

ILS in Million2021Weight2022Weight Delta
Ultrasound Systems
100.0 %
0 nan % 1 100.0 % -

Sales per region

ILS in Million2021Weight2022Weight Delta
Israel
100.0 %
0 nan % 1 100.0 % -

Managers

Managers TitleAgeSince
Ori Altschuler CEO
 Chief Executive Officer 41 22-01-17
Klein Tony Hanan DFI
 Director of Finance/CFO 44 15-11-14
Daniel Spira AUD
 Comptroller/Controller/Auditor 69 10-04-26

Members of the board

Members of the board TitleAgeSince
Orit Stav BRD
 Director/Board Member 53 22-10-19
Erez Navon CHM
 Chairman 50 21-02-23
Ronen Midbari BRD
 Director/Board Member 49 19-03-18
Arik Mor BRD
 Director/Board Member 65 21-08-29
Ohad Greenfeld BRD
 Director/Board Member 46 22-02-21

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 123,164,100 54,393,619 ( 44.16 %) 0 44.16 %

Shareholders

NameEquities%Valuation
Sigma Mutual Funds Ltd.
0.3557 %
438,086 0.3557 % 109 605 ILa
Migdal Mutual Funds Ltd.
0.0319 %
39,342 0.0319 % 9 843 ILa
Sigma PCM Mutual Funds Management Co. Ltd.
0.0228 %
28,117 0.0228 % 7 035 ILa
KSM Mutual Funds Ltd.
0.0153 %
18,821 0.0153 % 4 709 ILa

Holdings

NameEquities%Valuation
ENTERA BIO LTD.
10.42%
 3,732,540 10.42% 8,398,215 $

Company contact information

DNA Group (T.R.) Ltd.

43 Shimon HaTarsi Street

6249245, Tel Aviv

+

address Dna Group (T.R.) Ltd(DNA)

Sector

Healthcare
Pharmaceuticals & Medical Research
Biotechnology & Medical Research
Biotechnology & Medical Research
Other Biotechnology & Medical Research

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
DNA GROUP (T.R.) LTD Stock Dna Group (T.R.) Ltd
+13.92% 24.66M
MODERNA, INC. Stock Moderna, Inc.
+21.90% 46.93B
LONZA GROUP AG Stock Lonza Group AG
+37.63% 39.08B
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
-8.36% 38.48B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
+29.69% 31.01B
CELLTRION, INC. Stock Celltrion, Inc.
-13.75% 26.14B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+10.92% 25.88B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+36.18% 12.53B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-6.60% 11.36B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-12.34% 10.65B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. DNA Stock
  4. Company Dna Group (T.R.) Ltd